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Reactive oxygen species (ROS) production by immunological cells is known to cause damage
to pathogens. Increasing evidence accumulated in the last decade has shown, however, that
ROS (and redox signals) functionally regulate different cellular pathways in the host-pathogen
interaction. These especially affect (i) pathogen entry through protein redox switches and
redox modiﬁcation (i.e., intra- and interdisulﬁde and cysteine oxidation) and (ii) phagocytic ROS
production via Nox family NADPH oxidase enzyme and the control of phagolysosome function
with key implications for antigen processing. The protein disulﬁde isomerase (PDI) family of redox
chaperones is closely involved in both processes and is also implicated in protein unfolding and
trafﬁcking across the endoplasmic reticulum (ER) and towards the cytosol, a thiol-based redox
locus for antigen processing. Here, we summarise examples of the cellular association of host
PDI with different pathogens and explore the possible roles of pathogen PDIs in infection. A better
understanding of these complex regulatory steps will provide insightful information on the redox
role and coevolutional biological process, and assist the development of more speciﬁc therapeutic
strategies in pathogen-mediated infections.
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1. INTRODUCTION
Host cells have the ability to cope with the progression and severity of infection in response to different
types of pathogen. On the other hand, numerous mechanisms have evolved that support the use of the
host cell machinery to facilitate pathogen survival and multiplication. Such co-evolutionary processes
are directly affected by different physicochemical factors within different cell compartments, both in the
host and in pathogen. For instance, pH critically affects antigen stability of the inﬂuenza virus which
modulates endosome acidity that attenuates its own infection [1]. ROS (and Reactive Nitrogen Species)
production and the redox state of different cell compartments are also critically involved in cellular host-
parasite interaction. Among the many redox sensitive proteins that are altered during the course of different
infections, protein disulﬁde isomerase (PDI-) mediated redox switches have been associated with pathogen
attachment-internalization, antigen processing in the ER/phagosome, and the regulation of ROS production
by Nox family enzymes. Thus, PDI emerges as a ubiquitous redox protein that regulates different steps of
diverse infection processes. Several pathogens also have their own PDI that act as an important virulence
factor (Table 1). Other redox modiﬁcations directly mediated by ROS and especially via nitric oxide (NO)
generated by inducible nitric oxide synthase (iNOS), which is abundant in phagocytic cells, have been
reviewed elsewhere [2, 3] and are not considered in this article. Below, the main cellular redox aspects of
host and pathogen PDI will be discussed.
2. GENERAL ASPECTS OF PDI AND ITS ROLE IN HOST AND PATHOGEN
The ancient PDI is a ubiquitous redox chaperone belonging to the thioredoxin oxireductase super family
and can reduce (reaction 1), oxidize (reaction 2), and catalyse dithiol-disulﬁde exchange reactions (i.e.,
isomerase activities, reaction 3, Figure 1). Such broad range of activities overlaps with the chaperone role
of PDI that overall performs a housekeeping function in helping to maintain proteins in a more stable
conformation. There are around 20 PDI homologues, and the detailed structure and function of eukaryotic
PDIs have been covered in recent excellent reviews [4, 5]. The classic mammalian PDI (55kDa) has several
domains ordered as a-b-b -a -c with 2 thioredoxin-like motifs (Trp-Cys-Gly-His-Cys) displayed in the a
and a  domain [4–6]( Figure 1). PDI is abundant in the ER (∼ 0.5mM) where the relatively oxidizing
conditions at basal level (i.e., GSH/GSSG ratios ∼ 2-3 : 1) favours PDI isomerase/oxidase activity, which
is primarily involved in client protein redox folding (reaction 2-3, Figure 1). The oxidizing equivalents for
this process are driven mainly by the ER thiol-containing oxidase, Ero1 (endoplasmic reticulum oxidase-
1), which binds FAD and is in turn re-oxidized via electron transfer to oxygen, generating H2O2 in the
process [7–10]. The H2O2 destiny is elusive, but it can oxidize ER-located peroxiredoxin IV (PrxIV) that
is further reduced by PDI that is oxidized in the process [11]. This redox circuit is thought to increase
total protein folding and thiol oxidation via Ero1 [11]. However, even in the absence of Ero1, protein
folding still occurs, and it is suggested that other oxidases may compensate for redox demand in the ER
in some circumstances [12, 13]. Nevertheless, the PDI-Ero1-dependent oxidative activity is balanced to
cytosolic glutathione levels suggesting a functional redox interplay between these compartments [12]. PDI
reductase activity has been primarily associated to more reducing compartments (i.e., GSH/GSSG ratios
∼ 30–100 : 1), such as those in the vicinity of the plasma membrane [6, 10]. PDI redox versatility is mainly
governed by the low pKa of the proximal cysteine on the active N-terminal a domain. Indeed, the lower
pKa of 4.5 renders PDI a much better oxidase than thioredoxin, which has a pKa of 7.1 and is mainly a
reductase in most neutral pH cell compartments. It should also be noted that PDI functions as a chaperone
independently of its redox-active domains as especially required for its ATPase and Ca2+ activity, although
PDI redox motifs still stabilize binding interaction [4, 5, 10]. In the ER, PDI is tightly associated with
prolyl-4 hydroxylase (the rate-limiting enzyme for collagen biosynthesis), the Sec61 translocon, and the
MHC class I complex (see later). It can be also found as a heterodimer with microsomal triglyceride transfer
protein [6, 10]. PDI is a soluble homodimer and does not have a transmembrane domain and, similarly to
other ER chaperones, carries the KDEL C-terminal sequence which binds to respective receptors in the COP
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TABLE 1: Summary of the main PDI types and redox activity expressed in different groups of pathogens.
Pathogen group PDI (thioredoxin motif) Redox activity Reference
Leishmania major 5 isoforms (CGHC, CRYC) Oxidase-isomerase [16, 23, 24]
amazonensis 5 isoforms (CGHC, CRYC) Reductase-isomerase [16, 23, 24]
infantum 5 isoforms (CGHC) ND [23]
braziliensis 3 isoforms (CGHC) ND [23]
Trypanosoma cruzi 5 isoforms (CXXC) ND [25, 26]
Plasmodium falciparum 4 isoforms (2x CGHC) Oxidase-reductase [27, 28]
Toxoplasma gondii ND ND [29]
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FIGURE 1: PDI and its main reactions: upper, general display of the ﬁve domains of mammalian PDI protein
and showing the position of the active thioredoxin motif (WCGHC); lower, the main thiol redox reactions
driven by PDI on Pt (protein/peptide) substrate containing thiols. Note that in reaction 3, the oxidation is
driven by H2O2, especially in the oxidising ER compartment.
vesicles that circulate in the ER-Golgi vicinity, recycling proteins back to ER. PDI also undergoes intense
intracellular trafﬁcking and is found on the surface of diverse prokaryotic and eukaryotic cells [14–16].
Despitelimitedknowledgeaboutthistrafﬁc,itispossiblethatPDIexitstheERthroughthetransloconSec61
pore and/or via secretory vesicles [17]. PDI is thought to attach to lipids, glycans, and integral membrane
proteins via electrostatic interactions at the cell plasma membrane [14, 15], where its reductive activity
mediates the infection of different pathogens (Figure 2, discussed later). PDI along with ERp57 have been
found in the nuclei in association to DNA and affecting transcriptional activity of NF-kb, AP-1, and STAT3
[15]. These transcriptional regulators are key elements in many inﬂammatory processes, but their functional
association to PDI and to different pathogen still elusive. In contrast to many other members of its family,
such as thioredoxin itself and Erp57, PDI is not normally found in the cytosol, where it is likely cleaved by
caspase-3 and -7 [18].
Protozoans and bacteria have their own PDIs (Table 1). The function of these PDIs in protein folding
is poorly understood; however, there are intriguing data correlating PDI expression and the pathogenicity
of several parasites, especially obligatory intracellular protozoans. Leishmania that leads to distinct types





























FIGURE 2: Main cellular routes involved in host mammalian PDI and pathogens.
of leishmaniases is a well-known example. The disease affects millions of individuals worldwide, and
more recently this parasite emerged as an important opportunistic infection among patients with HIV [19].
There is a large variety of Leishmania species that results in different infection manifestation, generally
classiﬁed as cutaneous (L. major, L. mexicana, L. amazonensis, L. braziliensis, etc.), diffuse cutaneous (L.
amazonensis), mucocutaneous (L. braziliensis), and visceral (L. donovani, L. chagasi, and/or L. infantum)
[20]. If L. chagasi is a subgroup of L. infantum brought to America by European colonist or other specie
in its own still a matter of controversy (see discussion in [21]). The infection cycle in the vertebrate host
and is initiated when Leishmania promastigote is injected into the skin by the insect vector. In the host,
the promastigote is phagocytised especially by macrophages, and further it is converted into intracellular
amastigote. Amastigote replicates inside the phagosome within the cell and is liberated after the cell lyses,
subsequently infecting other cells resulting in the progression to disease [21, 22]. L. amazonensis has at least
four PDIs, and the use of speciﬁc PDI inhibitors substantially affected parasite growth [23]. In L. major,
the increased levels of Leishmania PDI (LmPDI) expression and secretion at the parasite surface reﬂects
optimal protein folding balanced to parasite multiplication. Importantly, this is correlated to high virulence
of the parasite strains [16]. More recently, the use of LmPDI antigens to generate a vaccine for L. major
partially protected BALB/c animals and accelerated the cure of different strains of mice [24]. Similarly
to Leishmania species, other parasites of the trypanosomatid group such as Trypanosoma contain several
genes predicted to encode for PDIs, that can execute N-glycosylation and protein folding in the ER [25, 26].
AlthoughPDIwasconsideredessentialforT.bruceisurvival,PDIactivitywasnotessentialforthegrowthof
trypanosomes in vitro [26]. PDI is also expressed in different species of Plasmodium protozoans (Table 1),
the parasites that cause malaria [27, 28]. P. falciparum expresses at least nine different PDIs and the PfPDI-
8 has great similarity to the prototype PDI and is expressed during all stages of parasite life cycle. This PDI
facilitates the disulﬁde-dependent conformational folding of EBA-175 protein, an emerging candidate for
the development of malaria vaccines [28]. This is intriguing given that malaria parasites express proteins
with high content of cysteine, which are associated to parasite invasion and sequestration in the vertebrate
host and transmission into mosquito host [28]. Finally, Toxoplasma gondii PDI was identiﬁed in host tears,
suggesting an extracellular location and adhesion to host cells during the initial phase of infection [29].
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3. PDI AND HOST-PATHOGEN INTERACTION
Antigen presentation occur through two distinct pathways. Antigen presenting cells (APCs; especially
macrophages and dendritic cells; DCs) are long-lived cells that capture antigens and subsequently process
and present them at the cell surface, where they are recognized by T-lymphocytes. This process provides a
long-term adaptive immune response to fungi, bacteria, and parasite. After internalization by the APC,
antigens pass through phagosome/lysosome vesicles, where they form complexes with MHC class II
(Figure 2), which are recognized by helper CD4+ T lymphocytes (exogenous pathway). In contrast, self
cell antigens and virus synthesized within cells (mostly non-APCs) are degraded by the proteasome in
the cytosol and nucleus. In successive steps, the antigen is processed, folded, and incorporated into the
MHC class I (Figure 2) and the complex exposed on the cell surface, and recognized by cytotoxic CD8+ T
lymphocytes (endogenous pathway). These two pathways overlap and some antigens are presented by both
MHC class I and II, in a process called cross-presentation. This has been described in DCs responding
to viral infection, transplant rejection, and some autoimmune diseases and cancer. Moreover, a wide
range of pathogens passing or living in the phagosome such as Mycobacterium tuberculosis, Salmonella
typhimurium, Toxoplasma gondii, and especially Leishmania spp and Trypanosoma cruzi are all cross-
presentedin associationto high levelsof CD8+ T cells [31]. PDI aspart of the ER protein folding machinery
directly regulates antigen processing of the MHC class I complex [32–35]. Antigens that are degraded by
peptidases and proteasome to shorter peptides in the cytosol and nucleus can be further transported to the
ER through the TAP system, a transmembrane ER type of ATP-binding cassette (ABC) peptide transporter
family [36]. ER-located PDI interacts with the peptide-loading complex (PCL) that efﬁciently promotes
peptide assembly with MHC class I molecules and supporting the exit of the peptide-antigen complex
from the ER [32–34]. Other PCL components include calreticulin, tapasin, ERp57 (another PDI family
member), and the TAP transporter itself. Cells lacking PDI present much less peptide loading to MHC
class I and the disulﬁde bridge between the peptide and MHC groove remains in a reduced redox state
[32]. Normally, this interaction is affected by the redox exchange between PDI (predominantly oxidized)
and ERp57 (predominantly reduced) [32], a condition in which PDI favours the release of peptide-MHC
class I from the PCL and the antigen-MHCI complex is exited from ER [34]. In fact, PDI-bound peptide
facilitates the disassembly of the tapasin-ERp57 complex while the PDI unbound to the complex is unable
to interact with tapasin-ERp57, retaining MHC I molecules in the ER [34]. Overall, PDI redox activity
modulates the stability of the antigen peptide-MHC class I complex and further determines the transport
of the complex to the plasma membrane [32–35]. These redox effects may vary according to the type
of antigen and some pathogens interfere with this pathway to escape antigen process and evading CD8+
T-cells recognition. This is the case for US3 protein from human cytomegalovirus, which enhances PDI
degradation via the proteasome [32]. PDI participation in immune response, however, goes beyond its role
in the ER protein folding machinery and it acts at other cellular steps of host-pathogen interaction. PDI in
the ER is also thought to play a role in parasite phagocytosis, and the PDI displayed on the cell surface can
mediate the entry of some viral, bacterial, and protozoan. PDI is also implicated in protein unfolding and
trafﬁcking of some pathogenic antigens across the endoplasmic reticulum and towards the cytosol by the
endoplasmic reticulum-associated degradation system (ERAD). This is the main pathway where proteins
are retrotranslocated from the ER to cytosol and further degradated by the proteasome. Next, we discuss
some examples of the cellular association between host PDI and different pathogens.
3.1. PDI and the Phagocytic Process
Phagocytosis is the main gate for large microbes to enter into APCs. After binding and attaching to
the pathogen, these cells can internalize organisms and large particles even bigger then their own size,
which are then phagocytosed in an active process that involves intense membrane remodelling [37].
Proteomics studies accumulated over the last decade revealed the presence of ER chaperones in the isolated
phagosome, uncovering a process called ER-mediated phagocytosis [38–45]. ER chaperones were detected
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in phagosomes of macrophages exposed to different particulate material and pathogens, including latex-
beads opsonised or not with immunoglobulin G (IgG) or mouse serum (to facilitate entry through the FcR or
complement receptors), IgG-opsonized erythrocytes, promastigotes of Leishmania donovani derived from
wild-type cells or cell-surface LPG knockout, among other parasites [38]. A mix of ER and endocytic
vesicles in the formation of the parasitophorous vacuoles (PVs) during the uptake of different Leishmania
spp. was recently shown in macrophages overexpressing ER-tagged green ﬂuorescent protein [41]. The
presence of the ER proteins Sec61, Bip/Grp78, and PDI in the phagosome of APCs [38, 41] support the
idea that the ER provides the necessary machinery for antigen translocation from the phagosome to the
cytoplasm and thus, possibly converges MHC class I and class II antigen cross-presentation [42]( Figure 2).
There are several other complementary hypotheses on how peptides cross from phagosomes to cytoplasm
during the cross-presentation process [43, 44]. Neutrophils are short-lived cells (half-life of 4–8h in the
human circulation) and very active in the phagocytosis of large microbes such as bacteria, parasites, and
fungus. Contrary to APCs, neutrophils only contain restricted amounts of ER machinery and are thought to
lack the ER-mediated phagocytosis process [38].
Whether ER proteins functionally operate on phagocytosis-mediated infection has not been well
characterised yet. An important work has shown that Dictyostelium lacking both ER calreticulin and
calnexin present altered phagocytic cup formation and substantial decline in phagocytosis [45]. These two
proteins utilise Ca, and their disruption per se affects actin ﬁlaments and plasma membrane remodelling
during phagocytosis [45]. We recently showed that PDI is critically involved in Leishmania parasite
infection in vitro [22]. We showed that phagocytosis of promastigotes (but not amastigotes) of Leishmania
chagasi was signiﬁcantly inhibited by macrophage incubation with the thiol/PDI inhibitors DTNB,
bacitracin, phenylarsine oxide, and neutralizing PDI antibody in a parasite redox-dependent way [22]. The
phenylarsine response is of particular interest, since this arsenic compound may act similarly to antimonials,
widely used in leishmaniasis chemotherapy [46, 47]. PDI preferentially affects parasite internalization
and the phagocytosis of the promastigote forms is increased when wild-type PDI is overexpressed in
macrophages, an effect opposed by PDI knockdown. At later stages of infection (i.e., after 4h), PDI from
promastigote-infected J774 macrophages was immunoprecipitated and subsequently blotted with an anti-
Leishmania antibody revealing a parasite band at ∼ 94KDa [16, Figure 10(b), lane 5]. Subsequent removal
and analysis of this band by mass ﬁngerprint spectrometry showed a 58% match with elongation factor
2 (EF2) of L. major (Q4Q259; data not shown). The incubation of puriﬁed bovine PDI (Sigma, P3818)
and parasites did not yield any detectable protein complexes, suggesting that the macrophage milieu may
be important to sustain PDI-EF2 association [22]. Interestingly, Leishmania EF2 has important virulent
features and acts as a soluble antigen in lymphocyte stimulation in vitro [48] and in vivo [49]. Moreover,
proteomics studies revealed that EF2 is secreted during promastigote differentiation into the amastigote
stage with potential immunomodulatory proprieties in animal models [50]. Leishmania EF2 is therefore
of particular interest for Leishmania therapeutic interventions such as vaccines. Although our studies did
not address the role of the ER in mediating phagocytosis, these data provide compelling evidence for
a functional role of ER-PDI in a host-parasite interaction. Other mechanisms underlining PDI-mediated
L. chagasi promastigote phagocytosis involves its association to ROS production by phagocyte NADPH
oxidase and this is discussed next.
3.2. PDI and NADPH Oxidase Regulation
The NADPH oxidase (Nox) family of enzymes uses NADPH as an electron donor to convert oxygen to
superoxide anion (O2
•−), a precursor of H2O2 and other powerful oxidants such as hydroxyl radical and
peroxynitrite (in the presence of nitric oxide), collectively called ROS [3, 51, 52]. Each of the seven oxidase
family members is characterized by a distinct catalytic subunit (i.e., Nox1-5 and Duox1-2), and has differing
requirements for additional protein subunits [51, 52]. The prototypic member of the Nox family, Nox2
oxidase(orgp91phox oxidase),isbestknownforitsroleinneutrophilandmacrophagephagocytosis.Genetic
defects in the enzyme are related to chronic granulomatous disease, a condition in which affected children
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suffer from recurrent severe fungal and bacterial infections due to defective phagocyte function [51]. Each
Nox isoform forms heterodimers with a lower molecular weight p22phox subunit and is predicted to be
membrane-bound. Nox2 is normally quiescent and acutely activated by agonists such as PMA, LPG, and
cytokines in a tightly regulated process in which cytosolic subunits (p47phox, p67phox, p40phox,a n dR a c 1
in the case of macrophages and dendritic cells, or Rac2 in neutrophil) associate with the Nox2-p22phox
heterodimer to initiate enzyme activity [51, 52]. Nox2 also has electrogenic features [53] and in APC cells
is linked to the regulation of phagosome/lysosome pH and antigen processing [54, 55]. Usually, phagosome
acidity is maintained by a vacuolar ATPase (V-ATPase) that transports protons from the cytosol into the
phagosome lumen, therefore regulating the function of lysosome proteases in the fused phagolysosomes.
Savina et al. [56–58] have shown that Nox2-derived superoxide in the phagosomal vesicle promptly
consumes protons maintaining a higher pH ambient in dendritic cells during particle internalization, which
favours antigen processing and presentation [56–58]. Opposite results were found in macrophages [56–58].
The selective role of Nox2 in different phagocytic cells remains to be deﬁned. The jury is out on whether the
results shown in macrophages (association of Nox2 to Rab27a; a member of Rab family of GTPases) are
related to vesicle trafﬁc molecule assembly and quality, or rather associated to degradation processes [59].
Nox complex protein expression and function is greatly affected by redox compounds, and it is
especially regulated by PDI with implications for cell signalling [60]. The association of PDI to p22phox and
other Nox isoforms in different cell types, especially in vascular cells, has been previously described [60–
62]. A functional and spatial/physical interaction between PDI and the p22phox oxidase subunit was shown
in macrophages [22] and more recently between PDI and p47phox in neutrophils [62]. In macrophages,
PDI-Nox association was correlated to Leishmania infection in vitro [22]. It is well known that during
phagocytosis of Leishmania, Nox2 is activated and parasite uptake is inhibited by antioxidants such as
catalase [22]. Intriguingly, in the course of promastigote infection, some parasites evade that stressful
condition and convert themselves into intracellular amastigotes, multiplying and resulting in progression to
a disease process. Overall, our studies support the view that parasite phagocytosis/infection by macrophages
is a redox process mediated by PDI in at least two ways. Initially, PDI-NADPH oxidase increases ROS
production generating an oxidizing milieu, which seems to favour promastigote infection. The downstream
role of ROS generated by PDI-NADPH oxidase remains unknown but can be related to the unfolded protein
response signalling [63] or, similar to PDI-Ero1, to protein folding in the macrophage ER compartment
with key implications for antigen processing. Nevertheless, at later stages of infection, macrophage PDI
physically associates with Leishmania elongation factor-2 (as discussed earlier).
3.3. PDI Role on Cell Surface and Pathogen Attachment
Some viruses envelop their genetic material within a protein-coated capsid in a further lipid membrane
layout, for example, inﬂuenza virus, baculovirus, hepatitis-C, HIV, and Herpes virus. These enveloped
particles require successive steps to successfully entry and infect host cells. They usually ﬁrst attach onto
host receptors (and attachment factors), and their membranes fuse to interact with endosome vesicles that
trafﬁc the virus toward the endoplasmic reticulum, where it is uncoated. The proteins are ﬁnally transported
to the cytosol and nucleus [64]( Figure 2). There is convincing evidence showing that most viral infections
are strongly inﬂuenced by changes in the redox environment and that host PDI mediates infection of
enveloped viruses [65–70].
In the course of HIV infection, the virus ﬁrst binds to attachment factors, for example, mannose
binding C-type lectin receptor and intracellular adhesion molecule (ICAM-3) on the surface of host CD4+
T cells. The glycoprotein 120 (gp120) subunit of the virus envelope binds to immunoglobulin G of
CD4+ and undergoes conformational changes, allowing the virus to interact with its coreceptors, CXCR4
or CCR5. These interactions favour downstream conversions of gp41 envelope subunit to a competent
fusion conformation. Initial studies showed that membrane-impermeable PDI inhibitors and monoclonal
antibodies against PDI prevent HIV-1 infection [65]. It was then revealed that the domain D2 of the CD4 has
redox-active disulﬁde bonds and is regulated by thioredoxin [66]. Using membrane-impermeable reducing
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agents (especially arsenical-derived compounds) and labelling thiol reagents, it was demonstrated that
CD4+ reactive thiols critically drive HIV entry into cells [66]. Work from another group also revealed that
PDI, on the surface of HIV-1 target cells, reduces disulﬁde bonds of the recombinant envelope glycoprotein
gp120 (reaction 1, Figure 1), a reaction prevented by the usual PDI inhibitors [67]. Intriguingly, PDI
silencinginU373andHeLacellshadlittle impactonHIVinfectionitselfascomparedtotheeffectmediated
by general thiol inhibitors [68]. The reasons for this discrepancy remain to be elucidated and raise the
question whether the reductive effect of PDI is coupled to other redox proteins (e.g., thioredoxin or Nox’s)
that could amplify virus-CD4 redox association in some cells. It is noteworthy that in these later studies, PDI
knockdown on the cell surface was not evident as compared to massive loss of most PDIs within the ER;
an observation that supports the idea that PDI in the ER has little impact in HIV-mediated infection [68].
Thiol inhibitors also affect viral fusion as that mediated by the fusion (F) protein from the Paramyxovirus
Newcastle disease virus [69]. The overexpression of PDI family members PFDI and ERdj5 has also been
shown to signiﬁcantly catalyze the reduction of thiols in F protein, facilitating membrane fusion [70]. There
is evidence suggesting a possible association between PDI and infection mediated by some members of the
of Herpesviridae viruses family [71].
PDI is also implicated in the attachment of some bacteria from different species of Chlamydia [72–
74]. Chlamydia is an obligatory intracellular pathogen that causes diverse diseases in humans. The most
common species are Chlamydia trachomatis, which is sexually transmitted and can cause blindness and
infertility, and C. pneumoniae, which affects the respiratory tract. CHO cells have impaired endogenous PDI
expression due to a defect in truncated mRNA processing, thus providing a valuable model to understand
the effect of PDI-mediated cell-cell interaction and infection. These cells are very resistant to Chlamydia
infection showing impaired attachment, an effect restored by ectopic expression of PDI [73]. Similar to HIV
infection, the molecular mechanisms most likely include the reductive activity of PDI (reaction 1, Figure 1)
on the surface of CHO cells [72].
3.4. PDI and Antigen Translocation from ER to Cytosol
Crossing the endoplasmic reticulum (ER) membrane is an irreversible process for most proteins. In some
cases, however, this ﬂow is reversed and misfolded proteins retained in the ER are retrotranslocated
to the cytosol via ERAD to be degraded by the proteasome. This pathway is also exploited by small
pathogens, especially non-enveloped viruses and some bacterial toxins, to gain access to the cytosol. In
these cases, antigenic particles that reach the ER by different means suffer molecular redox rearrangements
and binding to PDI allowing them to be transported back to the cytosol or nucleus. Well-known examples
are infections mediated by Polyomaviruses (Py) and Simian virus 40 (SV40) extensively studied in the
ﬁeld of carcinogenesis. After SV40 interaction with the GM1 receptor on the cell surface, the particle
enters the host cell through endocytosis and trafﬁcs via the caveosome (a particular caveolin containing
endosome with neutral pH) towards the ER compartment [75, 76]. SV40-coated pentamers are linked to
each other by disulﬁde bonds between cysteine 104 (C104). Further isomerisation in the ER is crucial
for the viral uncoating process. In vitro cell screening shows that among all ER-resident proteins, PDI and
ERp57 more speciﬁcally regulate SV40 infection [75]. PDI silencing substantially decreasesSV40 infection
that is also dependent on some redox sensitive cysteines on the viral particle [75]. PDI cooperation with ER-
associated ERAD proteins Derlin-1 and Sel1L is Ca dependent and facilitates SV40 trafﬁc through ERAD
[75]. A similar pathway is used by some nonobligatory intracellular bacteria that exert their effect through
production of potent endotoxins, such as diphtheria toxin (DT) and cholera toxin (CT). These proteins
function similarly to some plant toxins, such as ricin and abrin. Conversion into toxic proteins involves
cleavage of their interchain disulﬁde bond, allowing them to trafﬁc into the endocytic pathway within the
host cell [77, 78]. In humans, CT is derived from the Bacterium Vibrio cholerae that causes cholera disease
and has 2 subunits (A1 and A2). The protein ﬁrst attaches to the host cell surface via GM1 and the subunit
A2, which contains a KDEL sequence, and is transported back to the ER (see earlier discussion). There,
PDI reduces and unfolds A2 and A1 that exit the ER via the Sec61 channel into the cytosol. PDI in the
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reduced state (reaction 1, Figure 1) binds to the toxin and subsequent oxidation of PDI, probably via Ero1α,
enables the release of CT toxin [79, 80]. The active polypeptide A1 efﬁciently modiﬁes a heterotrimeric G
protein in the cytosol that leads to massive loss of chlorine and water secretion by intestinal epithelial cells
in mammals, resulting in severe diarrhoea.
4. CONCLUSION
InthisarticlewehavereviewedthemaincellularaspectsofPDI-mediatedhostpathogeninteractionsandthe
pathways that are involved in viral, bacterial (including bacterial toxins), and parasitic infections. A number
of cellular mechanisms through which PDI modulates some speciﬁc cellular pathways in immune cells
have been described, such as redox-sensitive attachment, antigen presentation in the ER and exit from it,
and association to phagosome and ROS production by NADPH oxidase (Figure 2). Many of these responses
are antigen-speciﬁc and the precise mechanisms of action remain to be fully elucidated, especially in the
context of redox changes in cross-presentation phenomena. Moreover, little is known about the role of
PDI in infection per se, as well as how PDI signals to a more integrated cellular response to stress [63]. PDI
globalknockoutmiceareonlyviableuntilbirth,butpartialgene-modiﬁedmiceandalsomodiﬁedpathogens
will help to reveal the signiﬁcant redox role of PDI and its redox partners. Overall, PDI is a key regulator
that may propagate or limit the severity of the infection processes, depending on the infectious organism
involved. A better understanding of these complex regulatory steps will provide insightful information on
the redox role and coevolutional biological process, and assist the development of more speciﬁc therapeutic
strategies in pathogen-mediated infections.
ABBREVIATIONS
ER: Endoplasmic reticulum
MHC: Major histocompatibility complex
H2O2: Hydrogen peroxide
ERp57: A member of PDI family also know as glucose-regulated protein or 58-kD (GRP58)
NF-kB: Factor nuclear kappa B
AP-1: Activator protein 1
STAT-3: Signal transducer and activator of transcription 3.
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